Pettinga Financial Advisors LLC increased its stake in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report) by 57.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 45,767 shares of the company's stock after acquiring an additional 16,750 shares during the period. Pettinga Financial Advisors LLC owned 0.12% of Crescent Capital BDC worth $880,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Montag A & Associates Inc. bought a new stake in shares of Crescent Capital BDC in the 4th quarter worth approximately $35,000. C M Bidwell & Associates Ltd. bought a new stake in shares of Crescent Capital BDC in the 4th quarter worth approximately $39,000. Aquatic Capital Management LLC bought a new stake in shares of Crescent Capital BDC in the 4th quarter worth approximately $129,000. Generation Capital Management LLC bought a new stake in shares of Crescent Capital BDC in the 4th quarter worth approximately $192,000. Finally, Dynamic Technology Lab Private Ltd bought a new stake in shares of Crescent Capital BDC in the 4th quarter worth approximately $218,000. Institutional investors and hedge funds own 49.46% of the company's stock.
Analysts Set New Price Targets
Several research firms recently commented on CCAP. Keefe, Bruyette & Woods downgraded Crescent Capital BDC from an "outperform" rating to a "market perform" rating and cut their target price for the stock from $18.50 to $17.00 in a research report on Friday, May 16th. Raymond James cut their target price on Crescent Capital BDC from $20.00 to $17.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Wells Fargo & Company cut their target price on Crescent Capital BDC from $16.00 to $15.00 and set an "equal weight" rating for the company in a research report on Friday, May 16th. Finally, Wall Street Zen downgraded Crescent Capital BDC from a "hold" rating to a "sell" rating in a research report on Thursday. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $17.60.
View Our Latest Research Report on Crescent Capital BDC
Crescent Capital BDC Trading Down 0.8%
CCAP stock opened at $15.33 on Friday. The business has a fifty day moving average price of $16.07 and a 200 day moving average price of $18.01. Crescent Capital BDC, Inc. has a fifty-two week low of $13.54 and a fifty-two week high of $20.19. The stock has a market capitalization of $568.13 million, a price-to-earnings ratio of 7.70 and a beta of 0.63. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.32 and a quick ratio of 1.26.
Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last released its earnings results on Wednesday, May 14th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.52 by ($0.07). The firm had revenue of $42.13 million during the quarter, compared to analyst estimates of $45.08 million. Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. Analysts expect that Crescent Capital BDC, Inc. will post 2.09 EPS for the current fiscal year.
Crescent Capital BDC Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Monday, June 30th will be paid a $0.42 dividend. The ex-dividend date of this dividend is Monday, June 30th. This represents a $1.68 annualized dividend and a dividend yield of 10.96%. Crescent Capital BDC's dividend payout ratio (DPR) is currently 125.37%.
About Crescent Capital BDC
(
Free Report)
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
See Also
Want to see what other hedge funds are holding CCAP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Crescent Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.
While Crescent Capital BDC currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
